Updated criteria could open new possibilities for intervention before symptoms appear JDRF is leading a pertinent discussion in the diabetes field about what defines a diagnosis of type 1 diabetes (T1D). At the 14th Annual Rachmiel Levine Diabetes and Obesity Symposium today, Richard Insel, M.D., JDRF’s chief scientific officer, reviewed evidence supporting the need to […]
A clinical study published in PNAS provides further proof-of-concept that beta cell encapsulation holds real promise for making islet implantation a viable therapy for people with type 1 diabetes (T1D).
Since last year’s Walk, the money that YOUR teams raised made real things happen to improve the lives of those with T1D! *Thanks to our friends at the Panhandle branch for the info! Since we last walked
Leading experts from industry, academia, and government came together the second week of April in Bethesda, MD, to discuss innovation in the development of an artificial pancreas system at a workshop hosted by the National Institutes of Health, the Food and Drug Administration (FDA), and JDRF. A commercially-viable artificial pancreas system would mimic the biological […]
Walk Registration is OPEN! walk.jdrf.org Sunday, October 27th The Domain Alterra Parkway, Austin, TX, 78758 It is never too early to register for our upcoming Walk and start fundraising! Volunteer at The One Party April 26th Hyatt Lost Pines Come volunteer at our newest event – The One Party – One day you’re bound to […]
Walk Registration is OPEN! walk.jdrf.org Sunday, October 27th The Domain Alterra Parkway, Austin, TX, 78758 It is never too early to register for our upcoming Walk and start fundraising! Austin type 1 Adults Meetup! Wednesday, Martch 27th Austin Terrier 3435 Greystone Drive, 78731 http://www.meetup.com/Austin-Type-1-Adults/ This is a social group for adults with type 1 diabetes […]
The U.S. Food and Drug Administration (FDA) announced on November 9 the issuance of its final guidance for the development of artificial pancreas systems. The guidance incorporates nearly all of JDRF’s recommendations. This news represents a milestone victory for JDRF and the type 1 diabetes (T1D) community, as the technology is viewed by medical experts […]